Trevena, Inc. (TRVN)
Trevena, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing innovative pharmaceutical solutions for individuals suffering from central nervous system disorders. Its pipeline features several promising drug candidates: OLINVYK (Oliceridine) injection: A G protein-biased mu-opioid receptor (MOR) ligand engineered to manage acute pain ranging from moderate to severe. TRV027: Aimed at addressing acute lung injury, which contributes to acute respiratory distress syndrome (ARDS) and abnormal blood clotting in patients with COVID-19. TRV250: A G protein-biased delta-opioid receptor agonist under development for the treatment of acute migraine. TRV734: A small molecule G protein-biased MOR ligand designed for the management of both moderate-to-severe acute and chronic pain. TRV045: An innovative S1P modulator focused on providing relief for chronic pain. The company has also established a partnership with Imperial College London to investigate TRV027's potential in patients afflicted with COVID-19. Trevena, Inc., founded in 2007, operates from its headquarters in Chesterbrook, Pennsylvania.
Sector: Biotechnology
Industry: Biotechnology
Trevena, Inc.
- 1:25Reverse splitAug 13, 202425 shares → 1
- 1:25Reverse splitNov 10, 202225 shares → 1
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $3.13M | -$418K | $567K | $3.07M | $31K | $5.73M | $0 | $3.75M | $6.25M | $0 | $135K | $808K | $2.42M |
| YoY Growth | -847.6% | -173.7% | -81.5% | 9800.0% | -99.5% | - | - | -40.0% | - | - | -83.3% | -66.6% | - |
| Cost of Revenue | $1.67M | $3.02M | $954K | $182K | $108K | $0 | $490K | $0 | $44.07M | $40.55M | $18.76M | $13.29M | $0 |
| Gross Profit | $1.46M | -$3.44M | -$387K | $2.89M | -$77K | $5.73M | -$490K | $3.75M | -$37.82M | -$40.55M | -$18.63M | -$12.49M | $2.42M |
| Gross Margin | 46.6% | 822.0% | -68.3% | 94.1% | -248.4% | 100.0% | - | 100.0% | -605.2% | - | -13800.0% | -1546.2% | 100.0% |
| Research and Development | $16.33M | $18.21M | $13.43M | $13.12M | $13.29M | $15.82M | $48.97M | $89.96M | $44.07M | $40.55M | $18.76M | $13.29M | $15.11M |
| Selling, General, and Administrative | $20.41M | $34.73M | $38.11M | $19.25M | $13.21M | $18.98M | $19.64M | $16.08M | $12.8M | $9.4M | $4.72M | $3.12M | $3.06M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $614K | -$711K | $93K | $184K | $1K | $123K | $0 |
| Total Operating Expenses | $36.74M | $52.94M | $51.54M | $32.37M | $26.5M | $34.8M | $68.61M | $106.03M | $56.87M | $49.95M | $23.48M | $16.42M | $18.17M |
| Operating Income (EBIT) | -$35.29M | -$56.38M | -$51.92M | -$29.48M | -$26.58M | -$30.5M | -$70.39M | -$102.28M | -$50.62M | -$49.95M | -$23.35M | -$15.61M | -$15.75M |
| Operating Margin | -1129.2% | 13486.8% | -9157.8% | -960.7% | -85741.9% | -532.1% | - | -2727.5% | -809.9% | - | -17295.4% | -1932.9% | -650.5% |
| Interest Expense | $0 | $1.26M | $1K | $29K | $931K | $2.23M | $2.78M | $1.74M | $334K | $71K | $150K | $194K | $74K |
| Interest Income | $2.25M | $451K | $162K | $240K | $418K | $1M | $679K | $743K | $331K | $17K | $884 | $754 | $4K |
| Other Income (Expense) | -$4.68M | $2.71M | $337K | $416K | $1.71M | $459K | -$3.25M | -$711K | $93K | $249K | $94K | -$26K | -$60K |
| Income Before Tax (EBT) | -$39.97M | -$53.67M | -$51.59M | -$29.07M | -$24.87M | -$30.04M | -$71.86M | -$102.99M | -$50.53M | -$49.7M | -$23.25M | -$15.64M | -$15.81M |
| Income Tax Expense | $318K | $0 | $0 | $300K | $0 | $745K | $3.39M | -$246K | -$208K | $255K | $151K | $0 | $74K |
| Net Income | -$40.29M | -$53.67M | -$51.59M | -$29.37M | -$24.87M | -$30.78M | -$71.86M | -$102.99M | -$50.53M | -$49.7M | -$23.25M | -$15.64M | -$15.81M |
| Net Income Margin | -1289.2% | 12839.1% | -9098.4% | -957.0% | -80229.0% | -537.1% | - | -2746.5% | -808.5% | - | -17225.8% | -1936.1% | -652.9% |
| Supplementary Data | |||||||||||||
| EPS | -3.16 | -7.59 | -7.90 | -5.75 | -7.65 | -10.46 | -30.23 | -49.14 | -28.84 | -50.40 | -22.59 | -28.41 | -38.03 |
| Diluted EPS | -3.16 | -7.59 | -7.90 | -5.75 | -7.65 | -10.46 | -30.23 | -49.14 | -28.84 | -50.40 | -22.59 | -28.41 | -38.03 |
| Weighted Average OS | 14.19M | 7.07M | 6.53M | 5.10M | 3.67M | 2.94M | 2.38M | 2.10M | 1.75M | 986,224 | 1.03M | 550,432 | 415,723 |
| EBITDA | -$34.95M | -$52.03M | -$51.08M | -$28.66M | -$23.38M | -$28.43M | -$68.12M | -$101.01M | -$50.62M | -$49.71M | -$22.64M | -$14.65M | -$14.95M |
| EBITDA Margin | -1118.5% | 12447.8% | -9009.5% | -933.7% | -75412.9% | -495.9% | - | -2693.6% | -809.9% | - | -16771.8% | -1814.6% | -617.2% |
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $32.98M | $38.32M | $66.92M | $109.4M | $32.3M | $32.89M | $16.56M | $24.27M | $46.77M | $36.21M | $37.97M | $6.74M | $17.06M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $3.5M | $28.59M | $49.54M | $86.33M | $125.86M | $70.7M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $32.98M | $38.32M | $66.92M | $109.4M | $35.8M | $61.48M | $66.1M | $110.6M | $172.64M | $106.9M | $37.97M | $6.74M | $17.06M |
| Accounts Receivable | $0 | $0 | $0 | $71K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12K | $23K |
| Inventory | $0 | $906K | $2.35M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $102K | $92K |
| Other Current Assets | $2.23M | $1.78M | $1.45M | $9M | $0 | $0 | $0 | $0 | $1.89M | $669K | $2M | $102K | $92K |
| Total Current Assets | $35.2M | $41.01M | $70.72M | $119.04M | $37.49M | $62.09M | $67.49M | $112.39M | $174.53M | $107.57M | $41.92M | $7.01M | $17.44M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $4.86M | $5.71M | $6.55M | $7.37M | $8.18M | $3.39M | $3.81M | $1.06M | $696K | $553K | $343K | $910K | $1.68M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $11K | $13K | $15K | $0 | $0 | $0 | $0 |
| Long-Term Investments | $540K | $1.96M | $1.31M | $1.31M | $1.31M | $1.3M | $1.41M | $1.19M | $113K | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | -$1.41M | -$1.19M | -$113K | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $1.54M | $13K | $20K | $0 | $1.41M | $1.19M | $113K | $211K | $128K | $170K | $296K |
| Total Long-Term Assets | $5.4M | $7.67M | $9.4M | $8.7M | $9.51M | $4.69M | $5.23M | $2.27M | $824K | $764K | $471K | $1.08M | $1.97M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $40.6M | $48.68M | $80.12M | $127.74M | $46.99M | $66.78M | $72.72M | $114.65M | $175.35M | $108.34M | $42.39M | $8.09M | $19.41M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $2.3M | $2.37M | $4.55M | $1.69M | $1.05M | $1.42M | $1.42M | $8.75M | $6.75M | $4.34M | $545K | $459K | $623K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $5.04M | $12.56M | $12.43M | $5.04M | $0 | $0 | $0 | $2.09M | $194K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $5.17M | $0 | $0 | $0 | $0 | $3.75M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2.09M | $1.97M | $2.13M | $6.08M | $1.79M | $1.73M | $2.55M | $2.73M | $2.64M | $1.67M | $893K | $852K | $784K |
| Total Current Liabilities | $7.55M | $8.73M | $9.19M | $16.56M | $9.11M | $17.49M | $18.21M | $22.05M | $13.57M | $6.96M | $2.74M | $3.93M | $2.28M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $30.81M | $13.43M | $0 | $0 | $0 | $4.81M | $15.72M | $13.27M | $18.19M | $1.69M | $0 | $2.78M | $251K |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $5.47M | $5.48M | -$1 | $6K | $5K | $2.93M | $4.12M | $737K | $455K | $471K | $664K | $1.41M | $1.34M |
| Total Long-Term Liabilities | $40.71M | $24.35M | $6.31M | $7.11M | $7.81M | $7.76M | $19.88M | $14.03M | $18.65M | $2.17M | $664K | $4.2M | $1.71M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $48.26M | $33.08M | $15.49M | $23.67M | $16.92M | $25.25M | $38.09M | $36.07M | $32.22M | $9.13M | $3.4M | $8.13M | $3.99M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $108.34B | $120.56M | $58.96M | $58.64M |
| Common Stock | $17K | $8K | $165K | $160K | $94K | $82K | $62K | $56K | $51K | $39K | $958 | $682 | $654 |
| Retained Earnings | -$588.06M | -$547.77M | -$494.1M | -$442.51M | -$413.14M | -$388.27M | -$357.49M | -$285.63M | -$182.5M | -$131.97M | -$82.27M | -$59.02M | -$43.38M |
| Comprehensive Income & Other | $0 | $1K | $0 | $0 | $0 | -$9K | -$42K | $2K | -$206K | -$19K | -$3.93M | -$3.23M | -$2.44M |
| Other Stockholders' Equity | $580.39M | $563.36M | $558.57M | $546.42M | $443.13M | $429.72M | $392.06M | $364.15M | $325.58M | $231.13M | $121.26M | $58.98M | $58.8M |
| Total Equity | -$7.66M | $15.6M | $64.63M | $104.07M | $30.08M | $41.53M | $34.63M | $78.58M | $143.13M | $99.2M | $38.99M | -$39K | $15.42M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $40.6M | $48.68M | $80.12M | $127.74M | $46.99M | $66.78M | $72.72M | $114.65M | $175.35M | $108.34M | $42.39M | $8.09M | $19.41M |
| Supplementary Data | |||||||||||||
| Total Debt | $36.24M | $19.77M | $7.1M | $7.8M | $13.46M | $17.39M | $28.18M | $18.33M | $18.19M | $1.8M | $0 | $4.87M | $445K |
| Net Debt | $3.27M | -$18.55M | -$59.82M | -$101.6M | -$18.84M | -$15.5M | $11.62M | -$5.94M | -$28.58M | -$34.4M | -$37.97M | -$1.87M | -$16.62M |
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$40.29M | -$53.67M | -$51.59M | -$29.37M | -$24.87M | -$30.78M | -$71.86M | -$102.99M | -$50.53M | -$49.7M | -$23.25M | -$15.64M | -$15.81M |
| Depreciation & Amortization | $334K | $382K | $428K | $477K | $562K | $645K | $490K | $246K | $208K | $239K | $707K | $788K | $802K |
| Deferred Income Tax | $0 | $0 | -$6K | $3K | -$360K | -$14K | $479K | $1.27M | $1.29M | -$117K | -$241K | -$45K | -$6K |
| Stock-Based Compensation | $2.93M | $3.68M | $4.41M | $3.28M | $3.23M | $4.37M | $6.39M | $5.9M | $3.43M | $2.38M | $928K | $176K | $181K |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | $522K | $1.21M | -$2.34M | $1.05M | -$1.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $10K | -$624K | -$2.35M | -$3.41M | $1.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$1.4M | -$676K | $1.53M | $3.41M | -$1.26M | -$1.16M | -$8.41M | $7.13M | $2.82M | $4.19B | $1.17B | $0 | $0 |
| Other Working Capital | $512K | -$758K | -$695K | $2.8M | -$1.6M | -$375K | $612K | -$3.65M | $2.53M | -$4.18B | -$1.17B | -$138K | $1.54M |
| Total Working Capital Change | -$355K | -$849K | -$3.85M | $3.85M | -$2.86M | -$375K | -$7.8M | $3.48M | $5.35M | $7.38M | -$2.5M | -$138K | $1.54M |
| Other Non-Cash Items | $4.34M | -$1.02M | $413K | $361K | $632K | $786K | $1.05M | $534K | $180K | $33K | $121K | $49K | $11K |
| Net Cash from Operating | -$33.03M | -$51.48M | -$50.2M | -$21.39M | -$23.67M | -$25.38M | -$71.25M | -$91.55M | -$40.07M | -$39.78M | -$24.24M | -$14.81M | -$13.28M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$41K | -$28K | -$16K | -$27K | $0 | -$169K | -$3.5M | -$605K | -$376K | -$440K | -$140K | -$21K | -$98K |
| Acquisitions | $0 | -$46K | $0 | $0 | $0 | -$21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$32.95M | $0 | $0 | -$53.81M | -$47.81M | -$62.74M | -$77.42M | -$56.56M | -$70.72M | $0 | $0 | $0 |
| Sales of Investments | $0 | $33M | $0 | $3.5M | $79.39M | $68.98M | $99.02M | $115.82M | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $46K | $0 | $0 | $0 | $21M | $36.27M | $38.4M | -$56.58M | -$70.72M | $0 | $0 | $0 |
| Net Cash from Investing | -$41K | $18K | -$16K | $3.47M | $25.58M | $21M | $32.78M | $37.8M | -$56.94M | -$71.16M | -$140K | -$21K | -$98K |
| Financing Activities | |||||||||||||
| Debt Repaid | -$14.76M | -$13.9M | $8K | $5.05M | $12.68M | $12.68M | -$9.91M | $4K | -$16.36M | -$1.77M | $4.95M | -$4.5M | $903K |
| Common Stock Issuance | $11.55M | $8M | $7.95M | $101.01M | $10.31M | $33.2M | $20.71M | $32.08M | $90.31M | $107.29M | $59.92B | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$2K | -$37K | -$206K | -$935K | -$130K | $83K | $361K | $256K | $906K | $112K | $634K | $3K | $0 |
| Net Cash from Financing | $26.31M | $23.5M | $7.73M | $95.02M | -$2.5M | $20.6M | $30.99M | $32.33M | $107.58M | $109.18M | $55.61M | $4.51M | $16.58M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$6.76M | -$27.95M | -$42.48M | $77.1M | -$581K | $16.23M | -$7.49M | -$21.43M | $10.57M | -$1.76M | $31.23M | -$10.32M | $3.2M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$33.03M | -$51.48M | -$50.2M | -$21.39M | -$23.67M | -$25.38M | -$71.25M | -$91.55M | -$40.07M | -$39.78M | -$24.24M | -$14.81M | -$13.28M |
| Capital Expenditure | -$41K | -$28K | -$16K | -$27K | $0 | -$169K | -$3.5M | -$605K | -$376K | -$440K | -$140K | -$21K | -$98K |
| Free Cash Flow | -$33.08M | -$51.51M | -$50.21M | -$21.42M | -$23.67M | -$25.54M | -$74.75M | -$92.16M | -$40.45M | -$40.22M | -$24.38M | -$14.83M | -$13.38M |
| Cash at Beginning | $40.28M | $68.23M | $110.71M | $33.61M | $34.2M | $17.97M | $25.46M | $46.89M | $36.21M | $37.97M | $6.74M | $17.06M | $13.86M |
| Cash at End | $33.52M | $40.28M | $68.23M | $110.71M | $33.61M | $34.2M | $17.97M | $25.46M | $46.77M | $36.21M | $37.97M | $6.74M | $17.06M |